0001493152-23-044874.txt : 20231214 0001493152-23-044874.hdr.sgml : 20231214 20231214163937 ACCESSION NUMBER: 0001493152-23-044874 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231214 DATE AS OF CHANGE: 20231214 EFFECTIVENESS DATE: 20231214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PD Theranostics, Inc. CENTRAL INDEX KEY: 0001830286 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-499738 FILM NUMBER: 231487577 BUSINESS ADDRESS: STREET 1: 575 FIFTH AVE., 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 646-414-6965 MAIL ADDRESS: STREET 1: 575 FIFTH AVE., 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 D 1 primary_doc.xml X0708 D LIVE 0001830286 PD Theranostics, Inc. 12 E 49TH STREET 11TH FLOOR NEW YORK NY NEW YORK 10017 646-335-5923 DELAWARE None None Corporation true 2019 Patrick Gallagher 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Executive Officer Director Chief Executive Officer Matthew Duffy 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Executive Officer Director President, Treasurer, Secretary James Ahern 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Director Matthew Eitner 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Director Biotechnology Decline to Disclose 06b false 2022-07-12 false true true false 0 Laidlaw & Company (UK) Ltd. 119037 None None 521 FIFTH AVENUE, 12TH FLOOR NEW YORK NY NEW YORK 10175 TX TEXAS false 1000000 150000 850000 false 2 15000 true 0 60000 The Company will use a portion of net pf proceeds to repay a promissory note in the principal amount of $60,000 issued to Matthew Eitner, the Chief Executive Officer of the placement agent and member of the Board of Directors of the Company. false PD Theranostics, Inc. /s/ Matthew Duffy Matthew Duffy President 2023-12-14